5005 MCCONNELL AVE, LOS ANGELES, CA
Market cap: $296.7M (2/12/2026)
Price: $8.15
Armata Pharmaceuticals Enters Credit Agreement Amendments Extending Maturity
Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated Staphylococcus aureus Bacteremia
Armata Pharmaceuticals Enters $100 Million Capital on Demand Sales Agreement
Announces Third Quarter 2025 Results and Provides Corporate Update
Phase 2a Trial of Bacteriophage Cocktail (AP-SA02) vs. Placebo in Staphylococcus aureus Bacteremia
Corporate Presentation Deborah Birx, M.D. Chief Executive Officer 27 th Annual Global Investment Conference September 10, 2025
Announces Second Quarter 2025 Results and Provides Corporate Update
Shareholder votes
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Submission Upload
Correspondence